Nektar Therapeutics (NKTR)
NASDAQ: NKTR
· Real-Time Price · USD
27.24
0.55 (2.06%)
At close: Aug 15, 2025, 3:59 PM
26.80
-1.62%
After-hours: Aug 15, 2025, 07:25 PM EDT
Nektar Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 42.99M | 38.89M | 44.25M | 30.11M | 13.92M | 34.74M | 20.16M | 64.92M | 50.73M | 76.95M | 88.23M | 105.76M | 77.55M | 67.99M | 25.22M | 54.02M | 152.34M | 150.16M |
Short-Term Investments | 132.91M | 179.74M | 210.97M | 214.39M | 257.31M | 254.49M | 283.45M | 307.74M | 358.7M | 379.87M | 416.75M | 440.63M | 541.77M | 599.03M | 708.74M | 867.06M | 847.72M | 887.15M |
Long-Term Investments | 5.37M | 9.78M | 26.09M | 4.54M | 19.41M | 36.78M | 25.82M | n/a | n/a | n/a | n/a | n/a | 8.93M | 37.36M | 64.83M | 34.22M | 57.4M | 96.09M |
Other Long-Term Assets | 5.02M | 5.39M | 4.65M | 4.52M | 4.31M | 4.66M | 4.64M | 4.52M | 1.65M | 1.41M | 2.25M | 2.32M | 2.23M | 1.52M | 2.74M | 1.84M | 344K | 1.44M |
Receivables | 1.35M | 1.71M | 1.61M | 2.12M | 2.9M | 5.43M | 2.25M | 3.43M | 1.33M | 3M | 5.98M | 11.53M | 10.01M | 30.22M | 22.49M | 28.99M | 28.87M | 29.16M |
Inventory | n/a | n/a | n/a | n/a | 14.46M | 16.24M | 16.1M | 15.13M | 20.69M | 20.23M | 19.2M | 19.06M | 16.97M | 15.38M | 15.8M | 15.33M | 14.62M | 16.81M |
Other Current Assets | n/a | n/a | n/a | 33.05M | n/a | n/a | n/a | n/a | 2.53M | n/a | 15.81M | 22.51M | 19.25M | 20.83M | 23.33M | 20.73M | n/a | 15.77M |
Total Current Assets | 186.57M | 229.91M | 261.29M | 286.48M | 295.19M | 319.84M | 330.7M | 399.02M | 441.06M | 491.07M | 545.97M | 599.48M | 665.54M | 733.46M | 795.58M | 986.13M | 1.06B | 1.1B |
Property-Plant & Equipment | 10.57M | 11.16M | 11.82M | 12.43M | 24.43M | 34.74M | 36.86M | 38.7M | 51.57M | 69.27M | 85.89M | 102.7M | 108.79M | 175.28M | 177.53M | 178.54M | 180.96M | 183.48M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 76.5M | 76.5M | 76.5M | 76.5M | 76.5M | 76.5M | 76.5M | 76.5M |
Total Long-Term Assets | 20.97M | 26.33M | 42.56M | 21.48M | 48.15M | 76.18M | 67.33M | 43.22M | 53.22M | 70.68M | 164.63M | 181.52M | 196.45M | 290.66M | 321.61M | 291.11M | 315.2M | 357.51M |
Total Assets | 207.53M | 256.24M | 303.85M | 307.97M | 343.33M | 396.01M | 398.03M | 442.24M | 494.28M | 561.74M | 710.6M | 781.01M | 861.99M | 1.02B | 1.12B | 1.28B | 1.37B | 1.46B |
Account Payables | 14.28M | 17.83M | 11.56M | 8.58M | 6.47M | 8.76M | 9.85M | 3.29M | 2.62M | 3.7M | 12.98M | 5.33M | 12.35M | 12.62M | 9.75M | 23.66M | 19.7M | 22.43M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 22.01M | n/a | n/a | n/a | n/a | 19.37M | 19.26M | 19.09M | 18.93M | n/a | n/a | 18.51M | 20.05M | 19.6M | n/a | 17.74M | 16.78M | 15.77M |
Other Current Liabilities | 35.1M | 5.03M | 5.55M | 37.5M | 20.8M | -2.47M | -2.65M | -843K | -461K | n/a | 26.98M | 17.25M | 22.22M | 30.82M | 42.28M | 47.95M | 49.1M | 46.15M |
Total Current Liabilities | 71.39M | 70.93M | 61.4M | 67.58M | 57.33M | 52.41M | 51.27M | 52.11M | 50.69M | 59.88M | 68.2M | 83.99M | 104.98M | 105.28M | 85.2M | 139.97M | 131.02M | 123.63M |
Long-Term Debt | 74.14M | n/a | 91.78M | 97.83M | 107.51M | 117.86M | 112.63M | n/a | n/a | n/a | 126.47M | n/a | n/a | n/a | 148.11M | n/a | n/a | n/a |
Other Long-Term Liabilities | 5.64M | 93.08M | 7.24M | 6.91M | 8.05M | 4.33M | 4.63M | 128.57M | 140.81M | 151.61M | 36.46M | 168.65M | 178.85M | 188.31M | 78.63M | 207.02M | 203.69M | 203.87M |
Total Long-Term Liabilities | 160.35M | 171.57M | 181.71M | 191.5M | 206.32M | 216.9M | 215.78M | 230.76M | 246.63M | 261M | 275.76M | 284.79M | 298.27M | 310.95M | 352.48M | 335.73M | 335.35M | 338.42M |
Total Liabilities | 231.75M | 242.5M | 243.11M | 259.08M | 263.65M | 269.31M | 267.05M | 282.88M | 297.32M | 320.88M | 343.96M | 368.78M | 403.25M | 416.23M | 437.68M | 475.7M | 466.38M | 462.06M |
Total Debt | 96.16M | 100.34M | 102.56M | 108.26M | 219.61M | 231.94M | 117.78M | 121.29M | 124.75M | 128.16M | 131.5M | 134.65M | 139.46M | 142.24M | 143.18M | 146.46M | 148.43M | 150.32M |
Common Stock | 1K | 19K | 19K | 19K | 19K | 19K | 19K | 19K | 19K | 19K | 19K | 19K | 19K | 19K | 19K | 18K | 18K | 18K |
Retained Earnings | -3.69B | -3.65B | -3.6B | -3.6B | -3.57B | -3.51B | -3.48B | -3.44B | -3.39B | -3.34B | -3.2B | -3.14B | -3.08B | -2.92B | -2.83B | -2.69B | -2.56B | -2.43B |
Comprehensive Income | -14K | 39K | 61K | 355K | -494K | -403K | 80K | -6.35M | -6.45M | -5.68M | -6.91M | -8.17M | -8.19M | -6.53M | -4.16M | -3.56M | -3.4M | -3.12M |
Shareholders Equity | -24.21M | 13.74M | 60.74M | 48.88M | 79.69M | 126.7M | 130.99M | 159.37M | 196.96M | 240.87M | 366.64M | 412.22M | 458.73M | 607.89M | 679.51M | 801.54M | 904.98M | 994.51M |
Total Investments | 156.35M | 189.51M | 237.06M | 218.92M | 276.72M | 291.27M | 309.28M | 307.74M | 358.7M | 379.87M | 416.75M | 440.63M | 550.7M | 636.39M | 773.57M | 901.28M | 905.12M | 983.25M |